In addition, SOX2 upregulates CD59 transcription in the epithelial cancer stem cells (24), and is stabilized via PI3K/AKT signaling to develop the resistance to R-CHOP regimen in diffuse large B cell lymphoma (DLBCL) (25). The gene discussed is SOX2; the disease is diffuse large B-cell lymphoma.